US · Healthcare

Keros Therapeutics Inc (KROS)

Biotechnology

Keros Therapeutics Inc (KROS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KROS

P/E ratio

18.00

Keros Therapeutics Inc (KROS) — FAQ

What is KROS's P/E ratio?

The price-to-earnings (P/E) ratio for Keros Therapeutics Inc (KROS) is 18.00 (data as of 2026-03-24).

Does Keros Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Keros Therapeutics Inc (KROS). Check the MyAverix Finance app for the latest dividend data.

What sector is Keros Therapeutics Inc in?

Keros Therapeutics Inc (KROS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is KROS listed on?

KROS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)